Grifols, S.A

(NASDAQ:GRFS)

Latest On Grifols, S.A (GRFS):

Date/Time Type Description Signal Details
2023-05-13 23:16 ESTNewsGrifols: Upside After A Smashing Q1 2023 - I Say 'Buy'N/A
2023-05-10 09:51 ESTNewsGrifols, S.A. (GRFS) Q1 2023 Earnings Call TranscriptN/A
2023-05-10 09:51 ESTNewsGrifols, S.A. 2023 Q1 - Results - Earnings Call PresentationN/A
2023-05-09 21:01 ESTNewsGrifols S.A. reports Q1 results; raises FY23 guidanceN/A
2023-05-08 18:06 ESTNewsGrifols names new CEO ending founding family’s leadershipN/A
2023-05-08 18:06 ESTNewsGrifols S.A. Q1 2023 Earnings PreviewN/A
2023-03-06 22:10 ESTNewsGrifols, Selagine team up to develop immunoglobulin eye dropsN/A
2023-03-03 14:59 ESTNewsGrifols downgraded at Morgan Stanley citing slower margin recoveryN/A
2023-03-01 04:10 ESTNewsGrifols, S.A. (GRFS) Q4 2022 Earnings Call TranscriptN/A
2023-03-01 04:10 ESTNewsGrifols, S.A. 2022 Q4 - Results - Earnings Call PresentationN/A
2023-02-27 22:34 ESTNewsGrifols S.A. FY 2022 Earnings PreviewN/A
2023-02-23 08:51 ESTNewsGrifols: A Favorite For Some, Speculative Buy For MeN/A
2023-02-15 18:35 ESTNewsGrifols cuts 8% staff mainly in U.S. as cost savings plan takes effectN/A
2022-12-07 04:30 ESTNewsGrifols upgraded to Overweight at Morgan StanleyN/A
2022-11-18 23:56 ESTNewsGrifols Needs To DeleverageN/A
2022-11-11 02:38 ESTNewsGrifols S.A. reports Q3 resultsN/A
2022-09-08 04:06 ESTNewsGrifols inks 15-year deal with Canada for plasma-derived therapiesN/A
2022-07-29 21:31 ESTNewsGrifols: Every Cloud Has A Silver LiningN/A
2022-05-10 18:31 ESTNewsGrifols: Long OnlyN/A
2022-05-09 20:47 ESTNewsGrifols stock slumps on Spain's stock exchange paring gains seen after Q1 resultsN/A
2022-03-31 03:27 ESTNewsGrifols jumps on report on takeover speculation (update)N/A
2022-03-15 13:03 ESTNewsGrifols ABvac40 vaccine for Alzheimer's shows safety/response in phase 2 interim dataN/A
2022-02-25 00:55 ESTNewsGrifols, Endpoint Health team up to develop Antithrombin III for SepsisN/A
2022-02-10 19:31 ESTNewsGrifols: Short-Term Turbulence But Long-Term UpsideN/A
2022-02-07 14:28 ESTNewsGrifols extends losses as JPMorgan points to downside risk to consensusN/A
2021-12-28 18:43 ESTNewsFDA updates EUA for COVID convalescent plasma limiting use to certain patientsN/A
2021-09-22 13:48 ESTNewsGrifols consolidates footprint in blood plasma with agreement to acquire BiotestN/A
2021-07-22 12:25 ESTNewsGrifols launches hepatitis B treatment HyperHEP BN/A
2021-07-22 12:25 ESTNewsGrifols sees revenue contribution from new product launches to ramp by 2030N/A
2021-07-22 12:25 ESTNewsGrifols presents at 2021 investor and analyst day - slideshowN/A
2021-07-22 12:16 ESTNewsGrifols: Valuation Discount Remains Wide Despite An Upbeat Capital Markets DayN/A
2021-06-03 06:11 ESTDividendA dividend of $0.46 has been announced on Nov 30, -0001. It will be paid Jun 14, 2021 with an ex-dividend date of Jun 3, 2021.Neutral
2021-04-29 02:40 ESTNewsGrifols shares rise after Andorra Development and Investment dealN/A
2021-04-21 10:06 ESTNewsGrifols: The Plasma-Supply Disruption Provides An Attractive Entry PointN/A
2021-03-18 23:26 ESTAnalyst RatingThe Analyst Target Price has increased from $27.19 to $27.38.Buy
2021-03-17 22:30 ESTEarnings EstimateAn EPS average of $1.56 is estimated for the 2022 year.Buy
2021-03-17 22:30 ESTEarnings EstimateAn EPS average of $0.38 is estimated for the quarter ending on June 30, 2021.Buy
2021-03-17 22:30 ESTAnalyst RatingThe Analyst Target Price has decreased from $27.31 to $27.19.Neutral
2021-03-16 22:48 ESTAnalyst RatingThe Analyst Target Price has decreased from $32.41 to $27.31.Neutral
2021-03-13 21:13 ESTAnalyst RatingThe Analyst Target Price has decreased from $32.49 to $32.41.Neutral
2021-03-13 05:02 ESTAnalyst RatingThe Analyst Target Price has increased from $32.34 to $32.49.Buy
2021-03-12 13:01 ESTAnalyst RatingThe Analyst Target Price has increased from $31.97 to $32.34.Buy
2021-03-12 05:18 ESTAnalyst RatingThe Analyst Target Price has increased from $31.9 to $31.97.Buy
2021-03-11 01:24 ESTAnalyst RatingThe Analyst Target Price has increased from $31.77 to $31.9.Buy
2021-03-10 05:30 ESTAnalyst RatingThe Analyst Target Price has decreased from $31.97 to $31.77.Neutral
2021-03-09 01:14 ESTAnalyst RatingThe Analyst Target Price has increased from $31.93 to $31.97.Buy
2021-03-07 09:09 ESTAnalyst RatingThe Analyst Target Price has decreased from $32.08 to $31.93.Neutral
2021-03-05 21:26 ESTAnalyst RatingThe Analyst Target Price has decreased from $32.27 to $32.08.Neutral
2021-03-05 12:54 ESTAnalyst RatingThe Analyst Target Price has decreased from $32.36 to $32.27.Neutral
2021-03-04 01:27 ESTAnalyst RatingThe Analyst Target Price has increased from $32.26 to $32.36.Buy

About Grifols, S.A (GRFS):

Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others segments. The Bioscience segment produces plasma-derived medicines for the treatment of rare, chronic, and life-threatening conditions. It offers intravenous immunoglobin, albumin, alpha-1-antitrypsin, factor VIII, antithrombin, and other specialty hyperimmune immunoglobulins. The Hospital segment offers non-biological pharmaceutical products and medical supplies for hospital pharmacy, such as intravenous solutions, pharmatech solutions, clinical nutrition products, and medical devices for interventional therapy. The Diagnostic segment manufactures and markets diagnostic testing equipment, reagents, and other equipment. The Bio Supplies segment provides biological products for non-therapeutic uses. The Others segment renders manufacturing services to third party companies. The company also provides engineering services; and rents industrial buildings. Its products and services are used by healthcare providers to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases, and other medical conditions. The company serves public and private customers; and wholesalers, distributors, group purchasing organizations, blood banks, hospitals and care institutions, and national health systems. Grifols, S.A. has a technology collaboration agreement with Mondragon. The company was founded in 1940 and is headquartered in Barcelona, Spain.

GRFS Quotes by TradingView

See Advanced Chart

General

  • Name Grifols, S.A
  • Symbol GRFS
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryDrug Manufacturers-General
  • Full Time Employees 23,655
  • Last Split Factor2:1
  • Last Split Date2016-01-04
  • Fiscal Year EndDecember
  • IPO Date2006-05-17
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.grifols.com
View More

Valuation

  • Trailing PE 27.04
  • Forward PE 11.99
  • Price/Sales (Trailing 12 Mt.) 1.73
  • Price/Book (Most Recent Quarter) 1.81
  • Enterprise Value Revenue 4.17
  • Enterprise Value EBITDA 15.63
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate $1.34
  • Next Year EPS Estimate $1.57
  • Next Quarter EPS Estimate $0.32
  • Profit Margin 12%
  • Return on Assets 5%
  • Return on Equity 10%
  • Earnings Per Share $0.60
  • Revenue Per Share $0
  • Gross Profit 2.51 billion
  • Quarterly Earnings Growth -3.8%
View More

Highlights

  • Market Capitalization 14.95 billion
  • PE Ratio 37.23
  • PEG Ratio 1.78
  • Analyst Target Price $27.38
  • Book Value Per Share $3.56
View More

Share Statistics

  • Shares Outstanding 684.54 million
  • Shares Float 856.69 million
  • % Held by Insiders <1%
  • % Held by Institutions 45.62%
  • Shares Short 3.8 million
  • Shares Short Prior Month 3.72 million
  • Short Ratio 4.17
  • Short % of Shares Outstanding 1%
View More

Technicals

  • Beta 0.05
  • 52 Week High $21.62
  • 52 Week Low $14.81
  • 50 Day Moving Average 16.54
  • 200 Day Moving Average 17.73
View More

Dividends

  • Forward Annual Dividend Rate $0.42
  • Forward Annual Dividend Yield 2.55%
  • Payout Ratio 16%
  • Dividend Date 2020-11-09
  • ExDividend Date 2020-10-30
  • Dividend Per Share $0.47
  • Dividend Yield 0%
View More

Grifols, S.A (GRFS) Dividend Calendar:

GRFS's last dividend payment was made to shareholders on November 9, 2020.
Grifols, S.A pays out 16% of its earnings out as a dividend.

Ex-Dividend Date Payment Date Record Date Declared Date Amount
2021-06-032021-06-142021-06-040000-00-00$0.46
2020-10-302020-11-092020-11-02$0.2
2019-12-022019-12-112019-12-032019-10-31$0.22
2019-06-072019-06-182019-06-102019-05-29$0.18
2018-11-302018-12-112018-12-032018-11-07$0.23
2018-06-012018-06-122018-06-042018-05-25$0.25
2017-12-012017-12-122017-12-04$0.21
2017-05-302017-06-082017-06-01$0.16
2016-12-052016-12-142016-12-07$0.19
2015-12-102015-12-172015-12-14$0.38
2015-06-082015-06-152015-06-10$0.34
2016-06-020000-00-002016-06-060000-00-00$0.16
2016-06-022016-06-06$0.16

Grifols, S.A (GRFS) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-26$1.31 billion$0.29$0.2515.82%
2020-09-302020-11-05$N/A$0.37$0.356.67%
2020-06-302020-07-30$N/A$0.36$0.37-1.33%
2020-03-312020-04-21$1.29 billion$0.24$0.30-18.58%
2019-12-312020-02-27$1.53 billion$0.31$0.31-1.63%
2019-09-302019-10-29$1.43 billion$0.28$0.30-7.05%
2019-06-302019-07-31$1.43 billion$0.33$0.320.12%
2019-03-312019-05-07$1.3 billion$0.25$0.25-1.32%
2018-12-312019-02-28$1.4 billion$0.24$0.31-22.87%
2018-09-302018-11-05$1.32 billion$0.29$0.31-5.83%
2018-06-302018-07-27$1.28 billion$0.34$0.326.69%
2018-03-312018-05-03$1.26 billion$0.28$0.29-3.76%
2017-12-312018-02-28$1.35 billion$0.29$0.31-8.1%
2017-09-302017-11-02$1.34 billion$0.28$0.30-4.31%
2017-06-302017-07-28$1.37 billion$0.28$0.281.53%
2017-03-312017-05-03$1.14 billion$0.27$0.261.71%
2016-12-312017-02-28$956.29 million$0.25$0.253.59%
2016-09-302016-11-08$1.16 billion$0.28$0.2511.6%
2016-06-302016-07-28$1.06 billion$0.26$0.27-5.56%
2016-03-312016-05-05$1.09 billion$0.23$0.24-4.25%
2015-12-312016-02-29$1.07 billion$0.24$0.27-11.48%
2015-09-302015-11-04$1.09 billion$0.26$0.2218.18%
2015-06-302015-07-30$1.14 billion$0.22$0.23-4.35%
2015-03-312015-05-07$975.7 million$0.25$0.244.17%
2014-12-312015-02-26$981.53 million$0.28$0.280%
2014-09-302014-11-04$873.66 million$0.28$0.30-6.67%
2014-06-302014-07-31$1.11 billion$0.32$0.306.67%
2014-03-312014-05-06$1.1 billion$0.24$0.28-14.29%
2013-12-312014-02-27$1.01 billion$0.16
2013-09-302013-11-05$973.55 million$0.16
2013-06-302013-07-31$920.25 million$0.18
2013-03-312013-05-02$876.23 million$0.18
2012-12-312013-02-28$936.82 million$0.12
2012-09-302012-10-31$851.15 million$0.07$0.13-46.15%
2012-06-302012-07-31$779.05 million$0.08$0.27-70.37%
2012-03-312012-04-24$888.95 million$0.13
2011-12-312012-02-29$708.12 million$0.00
2011-09-302011-11-11$698.63 million$0.05
2011-06-302011-07-28$551.92 million-$0.03

Grifols, S.A (GRFS) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Grifols, S.A (GRFS) Chart:

Grifols, S.A (GRFS) News:

Below you will find a list of latest news for Grifols, S.A (GRFS) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Grifols, S.A (GRFS) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-04-1710CALL0 0804.11TRUE00
2025-04-1720CALL0 0344.99TRUE00
2025-04-1730CALL0 0244TRUE00
2025-04-1740CALL0 0189.75TRUE00
2025-04-1750CALL0 0140.24TRUE00
2025-04-1760CALL0 086.18TRUE00
2025-04-1771.07CALL0 5033.37TRUE00
2025-04-1780.12CALL1 3456.77FALSE-0.03-0.2
2025-04-1790.05CALL0 41860.01FALSE00
2025-04-17100.25CALL0 1093.63FALSE00
2025-04-17110CALL0 0225.93FALSE00
2025-04-17120CALL0 0249.38FALSE00
2025-04-17130CALL0 0269.96FALSE00
2025-04-17140CALL0 0288.32FALSE00
2025-04-17150CALL0 0304.88FALSE00
2025-04-1710PUT0 0920.51FALSE00
2025-04-1720PUT0 0573.5FALSE00
2025-04-1730PUT0 0408.04FALSE00
2025-04-1740PUT0 0298.07FALSE00
2025-04-1750PUT0 0249.95FALSE00
2025-04-1760.15PUT0 7142.18FALSE00
2025-04-1770.25PUT0 37345.8FALSE00
2025-04-1780.57PUT0 37116.08TRUE00
2025-04-1790PUT0 090.49TRUE00
2025-04-17100PUT0 0102.35TRUE00
2025-04-17110PUT0 0124.03TRUE00
2025-04-17120PUT0 0188.15TRUE00
2025-04-17130PUT0 0207.28TRUE00
2025-04-17140PUT0 0270.06TRUE00
2025-04-17150PUT0 0190.27TRUE00
2025-05-1610CALL0 0979.89TRUE00
2025-05-1620CALL0 0241.58TRUE00
2025-05-1630CALL0 0171.55TRUE00
2025-05-1640CALL0 0187.85TRUE00
2025-05-1653CALL0 213102.93TRUE00
2025-05-1661.71CALL0 58101.66TRUE00
2025-05-1671.25CALL0 9332.61TRUE00
2025-05-1680.45CALL0 29447.4FALSE00
2025-05-1690.15CALL0 67463.15FALSE00
2025-05-16100.1CALL0 128127.6FALSE00
2025-05-16110.4CALL0 8126.9FALSE00
2025-05-16120.05CALL0 1141.01FALSE00
2025-05-16130.3CALL0 73153.41FALSE00
2025-05-16140CALL0 0164.49FALSE00
2025-05-16150.35CALL0 4174.5FALSE00
2025-05-16160CALL0 0183.62FALSE00
2025-05-16170CALL0 0192FALSE00
2025-05-1610PUT0 0578.67FALSE00
2025-05-1620PUT0 0359.77FALSE00
2025-05-1630PUT0 0255.39FALSE00
2025-05-1640PUT0 0185.96FALSE00
2025-05-1650.21PUT0 28132.6FALSE00
2025-05-1660.19PUT0 16256.93FALSE00
2025-05-1670.45PUT0 56445.73FALSE00
2025-05-1681.1PUT0 41346.88TRUE00
2025-05-1691.7PUT0 14738.22TRUE00
2025-05-16100PUT0 0202.09TRUE00
2025-05-16110PUT0 096.36TRUE00
2025-05-16120PUT0 0139.9TRUE00
2025-05-16130PUT0 0152.99TRUE00
2025-05-16140PUT0 0133.31TRUE00
2025-05-16150PUT0 0160.76TRUE00
2025-05-16160PUT0 0198.82TRUE00
2025-05-16170PUT0 0120.71TRUE00
2025-08-1510CALL0 0264.07TRUE00
2025-08-1520CALL0 0172.01TRUE00
2025-08-1530CALL0 0223.07TRUE00
2025-08-1540CALL0 0131.98TRUE00
2025-08-1553.5CALL0 7109.08TRUE00
2025-08-1561.7CALL0 877.7TRUE00
2025-08-1572.35CALL0 21070.45TRUE00
2025-08-1580.9CALL0 1846.67FALSE00
2025-08-1590.7CALL0 654.36FALSE00
2025-08-15100CALL0 057.5FALSE00
2025-08-15110.3CALL0 6064.06FALSE00
2025-08-15120.4CALL0 594.51FALSE00
2025-08-15130.1CALL0 194.18FALSE00
2025-08-15140CALL0 0100.65FALSE00
2025-08-15150CALL0 0106.5FALSE00
2025-08-15160CALL0 0111.83FALSE00
2025-08-1510PUT0 0339.14FALSE00
2025-08-1520PUT0 0209.45FALSE00
2025-08-1530PUT0 0147.57FALSE00
2025-08-1540.1PUT0 3106.3FALSE00
2025-08-1550.15PUT0 657.2FALSE00
2025-08-1560.35PUT1 3845.19FALSE-0.1-0.22
2025-08-1570.85PUT0 6727.84FALSE00
2025-08-1581.25PUT0 4153.3TRUE00
2025-08-1591.45PUT0 1458.71TRUE00
2025-08-15102.97PUT0 2059.36TRUE00
2025-08-15110PUT0 060.09TRUE00
2025-08-15120PUT0 069.17TRUE00
2025-08-15130PUT0 077.49TRUE00
2025-08-15140PUT0 094.97TRUE00
2025-08-15150PUT0 0102.02TRUE00
2025-08-15160PUT0 0112.93TRUE00
2025-11-2110CALL0 0230.1TRUE00
2025-11-2120CALL0 0175.48TRUE00
2025-11-2130CALL0 0139.2TRUE00
2025-11-2140CALL0 0120.56TRUE00
2025-11-2150CALL0 0102.25TRUE00
2025-11-2160CALL0 051.49TRUE00
2025-11-2170CALL0 073.67TRUE00
2025-11-2180CALL0 049.18FALSE00
2025-11-2190CALL0 053.08FALSE00
2025-11-21100CALL0 056.38FALSE00
2025-11-21110CALL0 058.93FALSE00
2025-11-21120CALL0 053.5FALSE00
2025-11-21130CALL0 060.69FALSE00
2025-11-21140CALL0 065.19FALSE00
2025-11-21150CALL0 0102.79FALSE00
2025-11-21160CALL0 0107.12FALSE00
2025-11-2110PUT0 0347.42FALSE00
2025-11-2120PUT0 0203.03FALSE00
2025-11-2130PUT0 0144.07FALSE00
2025-11-2140PUT0 061.96FALSE00
2025-11-2150PUT0 048.61FALSE00
2025-11-2160PUT0 036.32FALSE00
2025-11-2170.9PUT0 120.92FALSE00
2025-11-2180PUT0 046.3TRUE00
2025-11-2190PUT0 044.5TRUE00
2025-11-21100PUT0 026.83TRUE00
2025-11-21110PUT0 048.42TRUE00
2025-11-21120PUT0 0108.54TRUE00
2025-11-21130PUT0 0105.71TRUE00
2025-11-21140PUT0 00TRUE00
2025-11-21150PUT0 00TRUE00
2025-11-21160PUT0 073.82TRUE00
2025-12-1935.1CALL0 70146.91TRUE00
2025-12-1940CALL0 0124.91TRUE00
2025-12-1953.4CALL0 4873.78TRUE00
2025-12-1960CALL0 089.04TRUE00
2025-12-1971.99CALL0 442.28TRUE00
2025-12-1981.16CALL0 868.99FALSE00
2025-12-1990CALL0 053.63FALSE00
2025-12-19100.5CALL0 11963.4FALSE00
2025-12-19110CALL0 058.09FALSE00
2025-12-19120.75CALL0 8451.31FALSE00
2025-12-19150.2CALL0 12163.92FALSE00
2025-12-1930PUT0 0104.26FALSE00
2025-12-1940PUT0 055.35FALSE00
2025-12-1950.4PUT0 41155.11FALSE00
2025-12-1960.49PUT1 348.51FALSE-0.21-0.3
2025-12-1971.35PUT0 915.3FALSE00
2025-12-1980PUT0 049.22TRUE00
2025-12-1990PUT0 060.92TRUE00
2025-12-19100PUT0 00TRUE00
2025-12-19110PUT0 00TRUE00
2025-12-19120PUT0 035.08TRUE00
2025-12-19150PUT0 00TRUE00

Latest GRFS Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST24$11.835
Jun 13, 2022 7:59 PM EST80$11.835
Jun 13, 2022 7:59 PM EST80$11.835
Jun 13, 2022 7:59 PM EST142$11.835
Jun 13, 2022 7:59 PM EST10$11.83

Grifols, S.A (GRFS) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465920070749/0001104659-20-070749-index.htm
2019-02-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1438569/000031506619001082/0000315066-19-001082-index.htm
2019-07-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1438569/000031506619001598/0000315066-19-001598-index.htm
2018-05-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465918030037/0001104659-18-030037-index.htm
2018-05-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465918031927/0001104659-18-031927-index.htm
2018-05-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465918035864/0001104659-18-035864-index.htm
2018-06-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465918037898/0001104659-18-037898-index.htm
2018-06-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465918038773/0001104659-18-038773-index.htm
2018-06-19SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1438569/000110465918040970/0001104659-18-040970-index.htm
2018-07-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465918047551/0001104659-18-047551-index.htm
2018-08-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465918048670/0001104659-18-048670-index.htm
2018-09-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465918055714/0001104659-18-055714-index.htm
2018-10-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465918060259/0001104659-18-060259-index.htm
2018-10-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465918064237/0001104659-18-064237-index.htm
2018-11-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465918065575/0001104659-18-065575-index.htm
2018-11-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465918065887/0001104659-18-065887-index.htm
2018-11-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465918069526/0001104659-18-069526-index.htm
2018-11-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465918069680/0001104659-18-069680-index.htm
2018-12-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465918073562/0001104659-18-073562-index.htm
2018-12-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465918075244/0001104659-18-075244-index.htm
2019-02-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919011270/0001104659-19-011270-index.htm
2019-03-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919013238/0001104659-19-013238-index.htm
2019-03-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919018669/0001104659-19-018669-index.htm
2019-04-0520-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1438569/000110465919020063/0001104659-19-020063-index.htm
2019-04-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919021489/0001104659-19-021489-index.htm
2019-04-2320-F/AAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1438569/000110465919023085/0001104659-19-023085-index.htm
2019-05-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919026164/0001104659-19-026164-index.htm
2019-05-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919027308/0001104659-19-027308-index.htm
2019-05-246-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919031663/0001104659-19-031663-index.htm
2019-06-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919033920/0001104659-19-033920-index.htm
2019-07-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919039379/0001104659-19-039379-index.htm
2019-07-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919040426/0001104659-19-040426-index.htm
2019-07-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919042789/0001104659-19-042789-index.htm
2019-10-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919056835/0001104659-19-056835-index.htm
2019-10-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919057088/0001104659-19-057088-index.htm
2019-10-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919058031/0001104659-19-058031-index.htm
2019-11-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919062979/0001104659-19-062979-index.htm
2019-11-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919064554/0001104659-19-064554-index.htm
2019-11-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919065722/0001104659-19-065722-index.htm
2019-12-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919070538/0001104659-19-070538-index.htm
2019-12-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919070539/0001104659-19-070539-index.htm
2020-02-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465920022273/0001104659-20-022273-index.htm
2020-02-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465920026130/0001104659-20-026130-index.htm
2020-03-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465920038405/0001104659-20-038405-index.htm
2020-03-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465920039290/0001104659-20-039290-index.htm
2020-04-0620-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1438569/000110465920043470/0001104659-20-043470-index.htm
2020-04-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465920049070/0001104659-20-049070-index.htm
2020-05-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465920057912/0001104659-20-057912-index.htm
2020-06-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465920070749/0001104659-20-070749-index.htm
2020-07-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465920084649/0001104659-20-084649-index.htm
2020-07-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465920088132/0001104659-20-088132-index.htm
2020-09-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465920102386/0001104659-20-102386-index.htm
2020-09-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465920102797/0001104659-20-102797-index.htm
2020-10-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465920110940/0001104659-20-110940-index.htm
2020-10-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465920113682/0001104659-20-113682-index.htm
2020-10-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465920116641/0001104659-20-116641-index.htm
2020-11-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465920121561/0001104659-20-121561-index.htm